Profil
Vera Goossens worked as a Director-Lab Services at AlgoNomics NV and as a Principal at Fujirebio Europe NV from 2002 to 2007.
She received a doctorate degree from Ghent University in 1996.
Ehemalige bekannte Positionen von Vera Goossens
Unternehmen | Position | Ende |
---|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | 01.01.2007 |
AlgoNomics NV
AlgoNomics NV Pharmaceuticals: MajorHealth Technology AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium. | Corporate Officer/Principal | - |
Ausbildung von Vera Goossens
Ghent University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
AlgoNomics NV
AlgoNomics NV Pharmaceuticals: MajorHealth Technology AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium. | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |